About EstrAir

EstrAir is developing targeted airway therapies for symptoms that emerge during menopause — including chronic cough, throat dryness, voice change, and sleep disruption.

These conditions affect millions of women, yet the airway remains a profoundly overlooked area of women's health. There are currently no approved targeted treatments for menopause-related airway disease.

Our focus is localized, science-driven approaches that address symptoms at their source — beginning with sleep apnea.